Signal active
Contact Information
Social
Primary Organization
2012
51-100
Biotechnology, Pharmaceutical, Medical, Medical Device, Oncology
Bio
Specialized in Audit-Finance, Anne-Laure has acquired a seven-year experience within Deloitte before joining Effimune in 2013 as Administrative and Financial Manager. Upon the merger with OSE Pharma in 2016, Anne-Laure was appointed Chief Financial Officer of OSE Immunotherapeutics.
Anne-Laure Autret-Cornet graduated from ESSCA Management school.
Location
Nantes, Pays de la Loire, France, Europe
Jobs history
1
OSE Immunotherapeutics
Chief Financial Officer
Invalid date - Current
Educations
1
N/A
Profile Resume
Anne-Laure Autret-Cornet is the Chief Financial Officer at OSE Immunotherapeutics, based in Europe. With a background in Biotechnology, Anne-Laure Autret-Cornet has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.